Evidence map›Paper›PMID 34184637›Full record

ArticleeLife2021

Rapid feedback on hospital onset SARS-CoV-2 infections combining epidemiological and sequencing data.

Oliver Stirrup, Joseph Hughes, Matthew Parker, David G Partridge, James G Shepherd, James Blackstone, Francesc Coll, Alexander Keeley, Benjamin B Lindsey, Aleksandra Marek and 7 more

Abstract read
In one paragraph

Article in eLife, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Oliver StirrupInstitute for Global Health, University College London, London, United Kingdom.ORCID 0000-0002-8705-3281
Joseph HughesMRC-University of Glasgow Centre for Virus Research, Glasgow, United Kingdom.
Matthew ParkerSheffield Bioinformatics Core, The University of Sheffield, Sheffield, United Kingdom.
David G PartridgeSheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom.ORCID 0000-0002-0417-2016
James G ShepherdMRC-University of Glasgow Centre for Virus Research, Glasgow, United Kingdom.
James BlackstoneThe Comprehensive Clinical Trials Unit at UCL , University College London, London, United Kingdom.
Francesc CollDepartment of Infection Biology, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, United Kingdom.
Alexander KeeleySheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom.
Benjamin B LindseySheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom.ORCID 0000-0003-4227-2592
Aleksandra MarekClinical Microbiology, NHS Greater Glasgow and Clyde, Glasgow, United Kingdom.
Christine PetersClinical Microbiology, NHS Greater Glasgow and Clyde, Glasgow, United Kingdom.
Joshua B SingerMRC-University of Glasgow Centre for Virus Research, Glasgow, United Kingdom.
COVID-19 Genomics UK (COG-UK) consortium
Asif TamuriResearch Computing, University College London, London, United Kingdom.
Thushan I de SilvaSheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom.
Emma C ThomsonMRC-University of Glasgow Centre for Virus Research, Glasgow, United Kingdom.
Judith BreuerDivision of Infection and Immunity, University College London, London, United Kingdom.ORCID 0000-0001-8246-0534

Funding

Medical Research Council MC_PC_19026Medical Research Council MC_PC_19027NIHR IS-BRC-1215-20017Wellcome 201344/Z/16/ZWellcome Trust
6 · The paper itself

Abstract

Background: Rapid identification and investigation of healthcare-associated infections (HCAIs) is important for suppression of SARS-CoV-2, but the infection source for hospital onset COVID-19 infections (HOCIs) cannot always be readily identified based only on epidemiological data. Viral sequencing data provides additional information regarding potential transmission clusters, but the low mutation rate of SARS-CoV-2 can make interpretation using standard phylogenetic methods difficult. Methods: We developed a novel statistical method and sequence reporting tool (SRT) that combines epidemiological and sequence data in order to provide a rapid assessment of the probability of HCAI among HOCI cases (defined as first positive test >48 hr following admission) and to identify infections that could plausibly constitute outbreak events. The method is designed for prospective use, but was validated using retrospective datasets from hospitals in Glasgow and Sheffield collected February-May 2020. Results: We analysed data from 326 HOCIs. Among HOCIs with time from admission ≥8 days, the SRT algorithm identified close sequence matches from the same ward for 160/244 (65.6%) and in the remainder 68/84 (81.0%) had at least one similar sequence elsewhere in the hospital, resulting in high estimated probabilities of within-ward and within-hospital transmission. For HOCIs with time from admission 3-7 days, the SRT probability of healthcare acquisition was >0.5 in 33/82 (40.2%). Conclusions: The methodology developed can provide rapid feedback on HOCIs that could be useful for infection prevention and control teams, and warrants further prospective evaluation. The integration of epidemiological and sequence data is important given the low mutation rate of SARS-CoV-2 and its variable incubation period. Funding: COG-UK HOCI funded by COG-UK consortium, supported by funding from UK Research and Innovation, National Institute of Health Research and Wellcome Sanger Institute.

Indexed as

COVID-19Cross InfectionDisease OutbreaksGenome, ViralHospitalsHumansPopulation SurveillanceProbabilityRetrospective StudiesSARS-CoV-2United KingdomWhole Genome SequencingCOVID-19epidemiologyglobal healthhealthcare associatedhumaninfectious diseasemicrobiologynosocomialoutbreakSARS-CoV-2whole genome sequencing

Identifiers

PMID34184637
PMCPMC8285103

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.